REGN - REGENERON PHARMACEUTICALS, INC.
766.66
-24.150 -3.150%
Share volume: 636,991
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$790.81
-24.15
-0.03%
Summary score
77%
Profitability
77%
Dept financing
34%
Liquidity
75%
Performance
89%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
6.03%
Return on assets
5.8%
Return on sales
33.08%
Return on invested capital
10.65%
Total debt ratio
34.12%
Debt ratio change over timeo
0%
Current Ratio
3.28%
Quick Ratio
2.85%
Cash Position Ratio
0.69%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
6.06%
Return on assets
5.93%
Return on sales
33.92%
Return on invested capital
10.51%
Total debt ratio
34.1%
Debt ratio change over timeo
0%
Current Ratio
3.19%
Quick Ratio
2.74%
Cash Position Ratio
0.62%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
6.42%
Return on assets
6.44%
Return on sales
37.31%
Return on invested capital
11.33%
Total debt ratio
30.45%
Debt ratio change over time
0%
Current Ratio
3.63%
Quick Ratio
3.07%
Cash Position Ratio
0.7%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | REGN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 6.03% | 4.12% | 5.6% | 28.84% |
| Return on assets | 5.8% | 2.87% | 3.58% | 3.88% |
| Return on sales | 33.08% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | 10.65% | 4.34% | 6.5% | 4.27% |
| Profitability | 77% | 40% | 54% | 77% |
| Total debt ratio | 34.12% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 34% | 17% | 14% | 25% |
| Current Ratio | 3.19% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 2.74% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.62% | 0.31% | 0.62% | 0.55% |
| Liquididy | 75% | 32% | 55% | 47% |
| Short-term ratios | REGN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 6.06% | 3.9% | 5.53% | 29.97% |
| Return on assets | 5.93% | 2.93% | 3.51% | 3.83% |
| Return on sales | 33.92% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | 10.51% | 4.21% | 6.14% | 4.25% |
| Profitability | 78% | 40% | 53% | 76% |
| Total debt ratio | 34.1% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 34% | 18% | 14% | 25% |
| Current Ratio | 3.19% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 2.74% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.62% | 0.31% | 0.62% | 0.55% |
| Liquididy | 75% | 32% | 54% | 47% |